Biomarkers of alcohol consumption and related liver disease

References

• Leon DA, McCambridge J. Liver cirrhosis mortality rates in Britain from 1950 to 2002: an analysis of routine data. Lancet 2006;367:52–6.
   PubMed Web of Science ®Google Scholar
• Lieber CS. Medical disorders of alcoholism. N Engl J Med 1995;333:1058–65.
   PubMed Web of Science ®Google Scholar
• Room R, Babor T, Rehm J. Alcohol and public health. Lancet 2005;365:519–30.
   PubMed Web of Science ®Google Scholar
• Corrao G, Bagnardi V, Zambon A, La VC. A meta-analysis of alcohol consumption and the risk of 15 diseases. Prev Med 2004;38:613–9.
   PubMed Web of Science ®Google Scholar
• Gunzerath L, Faden V, Zakhari S, Warren K. National Institute on Alcohol Abuse and Alcoholism report on moderate drinking. Alcohol Clin Exp Res 2004;28:829–47.
   PubMed Web of Science ®Google Scholar
• Alatalo PI, Koivisto HM, Hietala JP, Puukka KS, Bloigu R, Niemelä OJ. Effect of moderate alcohol consumption on liver enzymes increases with increasing body mass index. Am J Clin Nutr 2008;88:1097–103.
   PubMed Web of Science ®Google Scholar
• Jou J, Choi SS, Diehl AM. Mechanisms of disease progression in nonalcoholic fatty liver disease. Semin Liver Dis 2008;28:370–9.
   PubMed Web of Science ®Google Scholar
• Vuppalanchi R, Chalasani N. Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: Selected practical issues in their evaluation and management. Hepatology 2009;49: 306–17.
   PubMed Web of Science ®Google Scholar
• Wu D, Cederbaum AI. Oxidative stress and alcoholic liver disease. Semin Liver Dis 2009;29:141–54.
   PubMed Web of Science ®Google Scholar
• Missiha SB, Ostrowski M, Heathcote EJ. Disease progression in chronic hepatitis C: modifiable and nonmodifiable factors. Gastroenterology 2008;134:1699–714.
   PubMed Web of Science ®Google Scholar
• Niemelä O. Biomarkers in alcoholism. Clin Chim Acta 2007;377:39–49.
   PubMed Web of Science ®Google Scholar
• Allen JP, Litten RZ. Recommendations on use of biomarkers in alcoholism treatment trials. Alcohol Clin Exp Res 2003; 27:1667–70.
   PubMed Web of Science ®Google Scholar
• Conigrave KM, Degenhardt LJ, Whitfield JB, Saunders JB, Helander A, Tabakoff B. CDT, GGT, and AST as markers of alcohol use: the WHO/ISBRA collaborative project. Alcohol Clin Exp Res 2002;26:332–9.
   PubMed Web of Science ®Google Scholar
• Das SK, Dhanya L, Vasudevan DM. Biomarkers of alcoholism: an updated review. Scand J Clin Lab Invest 2008;68: 81–92.
   PubMed Web of Science ®Google Scholar
• Niemelä O. Serum diagnosis of alcoholic liver disease and markers of ethanol intake. Sherman DIN, Preedy V, Watson RR. Ethanol and the liver. New York and London: Taylor and Francis; 2002. 411–49.
   Google Scholar
• Ozer J, Ratner M, Shaw M, Bailey W, Schomaker S. The current state of serum biomarkers of hepatotoxicity. Toxicology 2008;245:194–205.
   PubMed Web of Science ®Google Scholar
• Rockey DC, Bissell DM. Noninvasive measures of liver fibrosis. Hepatology 2006;43:S113–20.
   PubMed Web of Science ®Google Scholar
• Rosman AS, Lieber CS. Diagnostic utility of laboratory tests in alcoholic liver disease. Clin Chem 1994;40:1641–51.
   PubMed Web of Science ®Google Scholar
• Savola O, Niemelä O, Hillbom M. Blood alcohol is the best indicator of hazardous alcohol drinking in young adults and working-age patients with trauma. Alcohol Alcohol 2004;39: 340–5.
   PubMedGoogle Scholar
• Helander A, Böttcher M, Fehr C, Dahmen N, Beck O. Detection times for urinary ethyl glucuronide and ethyl sulfate in heavy drinkers during alcohol detoxification. Alcohol Alcohol 2009;44:55–61.
   PubMed Web of Science ®Google Scholar
• Böttcher M, Beck O, Helander A. Evaluation of a new immunoassay for urinary ethyl glucuronide testing. Alcohol Alcohol 2008;43:46–8.
   PubMed Web of Science ®Google Scholar
• Helander A, Olsson I, Dahl H. Postcollection synthesis of ethyl glucuronide by bacteria in urine may cause false identification of alcohol consumption. Clin Chem 2007;53:1855–7.
   PubMed Web of Science ®Google Scholar
• Helander A, Zheng Y. Molecular species of the alcohol biomarker phosphatidylethanol in human blood measured by LC-MS. Clin Chem 2009;55:1395–405.
   PubMed Web of Science ®Google Scholar
• Nissinen AE, Mäkelä SM, Vuoristo JT, Liisanantti MK, Hannuksela ML, Hörkkö S, Savolainen MJ. Immunological detection of in vitro formed phosphatidylethanol – an alcohol biomarker – with monoclonal antibodies. Alcohol Clin Exp Res 2008;32:921–8.
   PubMedGoogle Scholar
• Freeman TL, Tuma DJ, Thiele GM, Klassen LW, Worrall S, Niemela O, Parkkila S, Emery PW, Preedy VR. Recent advances in alcohol-induced adduct formation. Alcohol Clin Exp Res 2005;29:1310–6.
   PubMedGoogle Scholar
• Niemelä O, Parkkila S, Ylä-Herttuala S, Villanueva J, Ruebner B, Halsted CH. Sequential acetaldehyde production, lipid peroxidation, and fibrogenesis in micropig model of alcohol-induced liver disease. Hepatology 1995;22: 1208–14.
   PubMed Web of Science ®Google Scholar
• Latvala J, Hietala J, Koivisto H, Järvi K, Anttila P, Niemelä O. Immune responses to ethanol metabolites and cytokine profiles differentiate alcoholics with or without liver disease. Am J Gastroenterol 2005;100:1303–10.
   PubMedGoogle Scholar
• Jeppsson JO, Arndt T, Schellenberg F, Wielders JP, Anton RF, Whitfield JB, Helander A. Toward standardization of carbohydrate-deficient transferrin (CDT) measurements: I. Analyte definition and proposal of a candidate reference method. Clin Chem Lab Med 2007;45:558–62.
   PubMed Web of Science ®Google Scholar
• Anton RF, Lieber C, Tabakoff B. Carbohydrate-deficient transferrin and gamma-glutamyltransferase for the detection and monitoring of alcohol use: results from a multisite study. Alcohol Clin Exp Res 2002;26:1215–22.
   PubMed Web of Science ®Google Scholar
• Burke V, Puddey IB, Rakic V, Swanson NR, Dimmitt SB, Beilin LJ, Ching S, Beilby JP. Carbohydrate-deficient transferrin as a marker of change in alcohol intake in men drinking 20 to 60 g of alcohol per day. Alcohol Clin Exp Res 1998; 22:1973–80.
   PubMed Web of Science ®Google Scholar
• Mikkelsen IM, Kanitz RD, Nilssen O, Huseby NE. Carbohydrate-deficient transferrin: marker of actual alcohol consumption or chronic alcohol misuse? Alcohol Alcohol 1998; 33:646–50.
   PubMed Web of Science ®Google Scholar
• Schmidt LG, Schmidt K, Dufeu P, Ohse A, Rommelspacher H, Muller C. Superiority of carbohydrate-deficient transferrin to gamma-glutamyltransferase in detecting relapse in alcoholism. Am J Psychiatry 1997;154:75–80.
   PubMed Web of Science ®Google Scholar
• Hietala J, Koivisto H, Anttila P, Niemelä O. Comparison of the combined marker GGT-CDT and the conventional laboratory markers of alcohol abuse in heavy drinkers, moderate drinkers and abstainers. Alcohol Alcohol 2006;41:528–33.
   PubMed Web of Science ®Google Scholar
• Lee DH, Ha MH, Kam S, Chun B, Lee J, Song K, Boo Y, Steffen L, Jacobs DR, Jr. A strong secular trend in serum gamma-glutamyltransferase from 1996 to 2003 among South Korean men. Am J Epidemiol 2006;163:57–65.
   PubMed Web of Science ®Google Scholar
• Puukka K, Hietala J, Koivisto H, Anttila P, Bloigu R, Niemelä O. Additive effects of moderate drinking and obesity on serum gamma-glutamyl transferase activity. Am J Clin Nutr 2006;83:1351–4.
   PubMed Web of Science ®Google Scholar
• Kazemi-Shirazi L, Endler G, Winkler S, Schickbauer T, Wagner O, Marsik C. Gamma glutamyltransferase and long-term survival: is it just the liver? Clin Chem 2007;53:940–6.
   PubMed Web of Science ®Google Scholar
• Kim WR, Flamm SL, Di Bisceglie AM, Bodenheimer HC. Serum activity of alanine aminotransferase (ALT) as an indicator of health and disease. Hepatology 2008;47:1363–70.
   PubMed Web of Science ®Google Scholar
• Ruhl CE, Everhart JE. Elevated serum alanine aminotransferase and gamma-glutamyltransferase and mortality in the United States population. Gastroenterology 2009;136: 477–85.
   PubMed Web of Science ®Google Scholar
• Ruttmann E, Brant LJ, Concin H, Diem G, Rapp K, Ulmer H. Gamma-glutamyltransferase as a risk factor for cardiovascular disease mortality: an epidemiological investigation in a cohort of 163,944 Austrian adults. Circulation 2005;112:2130–7.
   PubMed Web of Science ®Google Scholar
• Lee TH, Kim WR, Benson JT, Therneau TM, Melton LJ, III. Serum aminotransferase activity and mortality risk in a United States community. Hepatology 2008;47:880–7.
   PubMed Web of Science ®Google Scholar
• Clark JM, Brancati FL, Diehl AM. The prevalence and etiology of elevated aminotransferase levels in the United States. Am J Gastroenterol 2003;98:960–7.
   PubMed Web of Science ®Google Scholar
• Ruhl CE, Everhart JE. Joint effects of body weight and alcohol on elevated serum alanine aminotransferase in the United States population. Clin Gastroenterol Hepatol 2005;3:1260–8.
   PubMed Web of Science ®Google Scholar
• Ioannou GN. Implications of elevated serum alanine aminotransferase levels: think outside the liver. Gastroenterology 2008;135:1851–4.
   PubMed Web of Science ®Google Scholar
• St George A., Bauman A, Johnston A, Farrell G, Chey T, George J. Independent effects of physical activity in patients with nonalcoholic fatty liver disease. Hepatology 2009;50: 68–76.
   PubMed Web of Science ®Google Scholar
• Goessling W, Massaro JM, Vasan RS, D’Agostino RB, Sr., Ellison RC, Fox CS. Aminotransferase levels and 20-year risk of metabolic syndrome, diabetes, and cardiovascular disease. Gastroenterology 2008;135:1935–44, 1944.
   PubMed Web of Science ®Google Scholar
• Suzuki A, Lymp J, Sauver JS, Angulo P, Lindor K. Values and limitations of serum aminotransferases in clinical trials of nonalcoholic steatohepatitis. Liver Int 2006;26:1209–16.
   PubMed Web of Science ®Google Scholar
• Alatalo P, Koivisto H, Puukka K, Hietala J, Anttila P, Bloigu R, Niemelä O. Biomarkers of liver status in heavy drinkers, moderate drinkers and abstainers. Alcohol Alcohol 2009;44: 199–203.
   PubMed Web of Science ®Google Scholar
• Ioannou GN, Dominitz JA, Weiss NS, Heagerty PJ, Kowdley KV. The effect of alcohol consumption on the prevalence of iron overload, iron deficiency, and iron deficiency anemia. Gastroenterology 2004;126:1293–301.
   PubMed Web of Science ®Google Scholar
• Bacon BR, Britton RS. The pathology of hepatic iron overload: a free radical-mediated process? Hepatology 1990;11:127–37.
   PubMed Web of Science ®Google Scholar
• Fletcher LM, Dixon JL, Purdie DM, Powell LW, Crawford DH. Excess alcohol greatly increases the prevalence of cirrhosis in hereditary hemochromatosis. Gastroenterology 2002;122: 281–9.
   PubMed Web of Science ®Google Scholar
• Tsukamoto H, Horne W, Kamimura S, Niemelä O, Parkkila S, Ylä-Herttuala S, Brittenham GM. Experimental liver cirrhosis induced by alcohol and iron. J Clin Invest 1995;96:620–30.
   PubMed Web of Science ®Google Scholar
• Lee DH, Jacobs DR, Jr. Serum markers of stored body iron are not appropriate markers of health effects of iron: a focus on serum ferritin. Med Hypotheses 2004;62:442–5.
   PubMed Web of Science ®Google Scholar
• Tyulina OV, Prokopieva VD, Boldyrev AA, Johnson P. Erythrocyte and plasma protein modification in alcoholism: a possible role of acetaldehyde. Biochim Biophys Acta 2006;1762: 558–63.
   PubMed Web of Science ®Google Scholar
• Arroyo V. Human serum albumin: not just a plasma volume expander. Hepatology 2009;50:355–7.
   PubMedGoogle Scholar
• Johnson RJ, Rivard C, Nakagawa T, Sautin YY, Sanchez-Lozada LG. Uric acid: more to learn, more experiments to do. Am J Hypertens 2009;22:952–3.
   PubMedGoogle Scholar
• Alatalo PI, Koivisto HM, Hietala JP, Bloigu RS, Niemelä OJ. Gender-dependent impacts of body mass index and moderate alcohol consumption on serum uric acid – an index of oxidant stress status? Free Radic Biol Med 2009;46:1233–8.
   PubMed Web of Science ®Google Scholar
• Cali AM, De Oliveira AM, Kim H, Chen S, Reyes-Mugica M, Escalera S, Dziura J, Taksali SE, Kursawe R, Shaw M, Savoye M, Pierpont B, Constable RT, Caprio S. Glucose dysregulation and hepatic steatosis in obese adolescents: is there a link? Hepatology 2009;49:1896–903.
   PubMed Web of Science ®Google Scholar
• Latvala J, Parkkila S, Niemelä O. Excess alcohol consumption is common in patients with cytopenia: studies in blood and bone marrow cells. Alcohol Clin Exp Res 2004;28:619–24.
   PubMed Web of Science ®Google Scholar
• Koivisto H, Hietala J, Anttila P, Parkkila S, Niemelä O. Long-term ethanol consumption and macrocytosis: diagnostic and pathogenic implications. J Lab Clin Med 2006;147:191–6.
   PubMed Web of Science ®Google Scholar
• Lindenbaum J. Hematologic complications of alcohol abuse. Semin Liver Dis 1987;7:169–81.
   PubMed Web of Science ®Google Scholar
• Bataller R, Brenner DA. Liver fibrosis. J Clin Invest 2005; 115:209–18.
   PubMed Web of Science ®Google Scholar
• Niemelä O, Risteli J, Blake JE, Risteli L, Compton KV, Orrego H. Markers of fibrogenesis and basement membrane formation in alcoholic liver disease. Relation to severity, presence of hepatitis, and alcohol intake. Gastroenterology 1990;98:1612–9.
   PubMed Web of Science ®Google Scholar
• Iredale JP. Models of liver fibrosis: exploring the dynamic nature of inflammation and repair in a solid organ. J Clin Invest 2007;117:539–48.
   PubMed Web of Science ®Google Scholar
• Koivisto H, Hietala J, Niemelä O. An inverse relationship between markers of fibrogenesis and collagen degradation in patients with or without alcoholic liver disease. Am J Gastroenterol 2007;102:773–9.
   PubMed Web of Science ®Google Scholar
• Vidali M, Hietala J, Occhino G, Ivaldi A, Sutti S, Niemela O, Albano E. Immune responses against oxidative stress-derived antigens are associated with increased circulating tumor necrosis factor-alpha in heavy drinkers. Free Radic Biol Med 2008;45:306–11.
   PubMed Web of Science ®Google Scholar
• Naveau S, Gaude G, Asnacios A, Agostini H, Abella A, Barri-Ova N, Dauvois B, Prevot S, Ngo Y, Munteanu M, Balian A, Njike-Nakseu M, Perlemuter G, Poynard T. Diagnostic and prognostic values of noninvasive biomarkers of fibrosis in patients with alcoholic liver disease. Hepatology 2009;49:97–105.
   PubMedGoogle Scholar
• Schenker S. Medical consequences of alcohol abuse: is gender a factor? Alcohol Clin Exp Res 1997;21:179–81.
   PubMed Web of Science ®Google Scholar
• Breitling LP, Raum E, Muller H, Rothenbacher D, Brenner H. Synergism between smoking and alcohol consumption with respect to serum gamma-glutamyltransferase. Hepatology 2009; 49:802–8.
   PubMed Web of Science ®Google Scholar
• Klatsky AL, Morton C, Udaltsova N, Friedman GD. Coffee, cirrhosis, and transaminase enzymes. Arch Intern Med 2006; 166:1190–5.
   PubMedGoogle Scholar
• Ioannou GN, Morrow OB, Connole ML, Lee SP. Association between dietary nutrient composition and the incidence of cirrhosis or liver cancer in the United States population. Hepatology 2009;50:175–84.
   PubMedGoogle Scholar
• Johnson NA, Sachinwalla T, Walton DW, Smith K, Armstrong A, Thompson MW, George J. Aerobic exercise training reduces hepatic and visceral lipids in obese individuals without weight loss. Hepatology 2009;50:1105–12.
   PubMed Web of Science ®Google Scholar
• Ristow M, Zarse K, Oberbach A, Kloting N, Birringer M, Kiehntopf M, Stumvoll M, Kahn CR, Bluher M. Antioxidants prevent health-promoting effects of physical exercise in humans. Proc Natl Acad Sci USA 2009;106:8665–70.
   PubMed Web of Science ®Google Scholar